TWO SIGMA ADVISERS, LP - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,520
-45.3%
19,400
-22.1%
0.00%
Q2 2023$28,386
-28.0%
24,900
-5.3%
0.00%
Q1 2023$39,450
-25.2%
26,300
-25.7%
0.00%
Q4 2022$52,746
-10.6%
35,400
-6.6%
0.00%
Q3 2022$59,000
-36.6%
37,900
-7.8%
0.00%
Q2 2022$93,000
-1.1%
41,100
+0.5%
0.00%
Q1 2022$94,000
-19.0%
40,900
+104.5%
0.00%
Q4 2021$116,000
-48.7%
20,000
-13.8%
0.00%
-100.0%
Q2 2021$226,000
+41.2%
23,200
+110.9%
0.00%
Q1 2021$160,00011,0000.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders